Cancer Nanotechnology Gordon Research Conference (GRC)

Cancer Nanotechnology Gordon Research Conference (GRC) is organized by Gordon Research Conferences (GRC) and would be held during Jun 18 - 23, 2017 at Mount Snow Grand Summit Resort, West Dover, Vermont, United States Of America.

The 2017 Cancer Nanotechnology Gordon Research Conference (GRC) provides a unique forum where scientists at every stage of their career can share unpublished, innovative cancer research made possible by the use of nanotechnology. Held biennially since 2011, the 2017 Cancer Nanotechnology GRC is shaping up to be one of the most exciting and important meetings in the field.

Nanotechnology is a burgeoning field of study in science and engineering. Its application for cancer diagnosis, imaging, therapy, and prognosis has been a focal point of attention in biomedicine. Most nanomedicine studies are concentrated in cancer. Due to the presence of leaky vasculature and defective lymphatic drainage in solid tumors, nanoparticles selectively accumulate in the tumor via the mechanism of the enhanced permeability and retention (EPR) effect. Thus, nanoparticles are uniquely suitable for delivering diagnostic and/or imaging agents, chemo and gene drugs, and agents to enhance the activity of immunotherapy to the tumor. Nanoparticles also offer an amplification mechanism for bioanalytical detection and sensor devices for cancer markers.